510(k) · Cleared
ClearedDepuy Sigma Cruciate Retaining Porocoat Femoral Components
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
DePuy Orthopaedics, Inc. · MBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer
Cleared on Sep 29, 2006 as substantially equivalent to K943462 (Johnson & Johnson Professionals, Inc., 1994) and 2 other predicates after a 22-day review. Its family tree reaches back 1 generation to 1994. 120 later devices descend from it.
- Decided
- Sep 29, 2006
- Review
- 22 days
- Class
- Class II
- Product code
- MBH
- Recalls
- None
- Predicates
- 3
Its longest line of descent runs back 1 generation to K933787 (1994). 3 ancestors in all. 120 later devices descend from it, 6 citing it directly.
- Root · 1 generation backK933787 Porocoat Porous Coating/Aml Proximally-Coated StemDepuy, Inc. · 1994
- This deviceK062654 Depuy Sigma Cruciate Retaining Porocoat Femoral ComponentsDePuy Orthopaedics, Inc. · 2006
- Descendant · cites it directly · 72 of its ownK073602 Modification to: Apex Knee SystemOmnlife Science · 2008
- Descendant · 2 generations on · 61 of its ownK080842 Apex Knee System, Model KC-230XY, KC-240XY [ NO Holes, 2 Holes]Omni Life Science, Inc. · 2008
- Descendant · 3 generations on · 60 of its ownK131353 Comprehensive Reverse Shoulder - Titanium GlenosphereBiomet Manufacturing Corp · 2013
- Descendant · cites it directly · 45 of its ownK101499 Journey CR Knee SystemSmith & Nephew, Inc. · 2010
- Descendant · 2 generations on · 37 of its ownK121443 Journey II CR Knee SystemSmith & Nephew, Inc. · 2012
Showing 5 of 120 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 120 · See all- K073602Modification to: Apex Knee SystemOmnlife Science · 2008 · cites it directly72descendants
- K080842Apex Knee System, Model KC-230XY, KC-240XY [ NO Holes, 2 Holes]Omni Life Science, Inc. · 2008 · 2 generations on61descendants
- K131353Comprehensive Reverse Shoulder - Titanium GlenosphereBiomet Manufacturing Corp · 2013 · 3 generations on60descendants
- K101499Journey CR Knee SystemSmith & Nephew, Inc. · 2010 · cites it directly45descendants
- K121443Journey II CR Knee SystemSmith & Nephew, Inc. · 2012 · 2 generations on37descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K933787 | Porocoat Porous Coating/Aml Proximally-Coated Stem | Depuy, Inc. | 1994 | — |
| 0 (this device) | K062654 | Depuy Sigma Cruciate Retaining Porocoat Femoral Components | DePuy Orthopaedics, Inc. | 2006 | — |
| +1 | K073602 | Modification to: Apex Knee System | Omnlife Science | 2008 | — |
| +2 | K080842 | Apex Knee System, Model KC-230XY, KC-240XY [ NO Holes, 2 Holes] | Omni Life Science, Inc. | 2008 | — |
| +3 | K131353 | Comprehensive Reverse Shoulder - Titanium Glenosphere | Biomet Manufacturing Corp | 2013 | — |
| +1 | K101499 | Journey CR Knee System | Smith & Nephew, Inc. | 2010 | — |
| +2 | K121443 | Journey II CR Knee System | Smith & Nephew, Inc. | 2012 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1994 | 1 | 0 |
| 1996 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2008 | 2 | 0 |
| 2010 | 1 | 0 |
| 2011 | 3 | 0 |
| 2012 | 3 | 0 |
| 2013 | 4 | 0 |
| 2014 | 4 | 0 |
| 2015 | 9 | 0 |
| 2017 | 3 | 0 |
| 2018 | 3 | 0 |
| 2019 | 8 | 0 |
| 2020 | 8 | 0 |
| 2021 | 11 | 0 |
| 2022 | 9 | 0 |
| 2023 | 9 | 0 |
| 2024 | 15 | 0 |
| 2025 | 12 | 0 |
| 2026 | 16 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MBH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MBH device
- #1 K241597 Freedom® Total Knee System - Porous Tibial…score 19.9 · 8 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (3)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K943462 | Darwin Knee SystemSummary page 1…JWH, MB3H SUBSTANTIALLY EQUIVALENT PFC Sigma® Knee System (cleared as Darwin DEVICES: Knee System), K943462 PFC Cruciate Retaining Knee System, Size 1.5,… | 1994 |
| * | K961685 | P.F.C. Cruciate Retaining Knee System (Size 1.5)Summary page 1…nee System), K943462 PFC Cruciate Retaining Knee System, Size 1.5, K961685 AML® Proximally Coated Hip, K933787 DEVICE 'DESCRIPTION: The Sigma C/R Por… | 1996 |
| * | K933787 | Porocoat Porous Coating/Aml Proximally-Coated StemSummary page 1…taining Knee System, Size 1.5, K961685 AML® Proximally Coated Hip, K933787 DEVICE 'DESCRIPTION: The Sigma C/R Porocoat Femoral Components are part of the Sigma Total Knee Replacement System. They are p… | 1994 |
| † | P830055 | LCS (R) Total Knee System | 1985 |
What descends from it? (120)
See all 1206 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K073602 | Modification to: Apex Knee System | 2008 | 72 |
| K101499 | Journey CR Knee System | 2010 | 45 |
| K140881 | Depuy Attune Knee System - Cementless CR and PS Femoral Componenets | 2015 | 3 |
| K182301 | PFC SIGMA Knee System | 2019 | 1 |
| K140302 | Optetrak Logic Porous Femoral Components | 2014 | 1 |
| K241000 | ATTUNE™ Revision Knee System; DePuy Knee Prosthesis System Universal Stem Extensions and… | 2024 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All MBH devicesMBH Prosthesis, Knee, Patello/Femorotibial, Semi-Constrained, Uncemented, Porous, Coated, Polymer/Metal/Polymer: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MBH
8in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MBH
98in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MBH
1in 2024
Class I (5 since 2007) Class II/III not classified
Adverse event reports per year · MBH
1,561in 2025
MAUDE reports naming product code MBH, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 10 | 59 | 0 | 27 |
| 2008 | 3 | 70 | 0 | 21 |
| 2009 | 3 | 209 | 2 | 89 |
| 2010 | 4 | 84 | 0 | 121 |
| 2011 | 5 | 84 | 15 | 247 |
| 2012 | 5 | 90 | 1 (1) | 370 |
| 2013 | 6 | 138 | 4 (4) | 308 |
| 2014 | 9 | 114 | 0 | 385 |
| 2015 | 8 | 100 | 0 | 955 |
| 2016 | 4 | 74 | 1 | 1,034 |
| 2017 | 4 | 115 | 9 | 1,007 |
| 2018 | 6 | 89 | 1 | 1,191 |
| 2019 | 1 | — | 1 | 1,394 |
| 2020 | 7 | 112 | 2 | 1,089 |
| 2021 | 6 | 48 | 0 | 1,539 |
| 2022 | 7 | 57 | 0 | 1,261 |
| 2023 | 6 | 94 | 2 | 1,263 |
| 2024 | 10 | 84 | 1 | 1,497 |
| 2025 | 8 | 98 | 0 | 1,561 |
| 2026 | 7 | 153 | 4 | — |
What is it indicated for?
The Sigma Cruciate Retaining Porocoat Femoral Components are intended for cemented or cementless use as the femoral components of a Total Knee Replacement system. Total Knee Replacement is intended to provide increased patient mobility and reduced pain by replacing the damaged knee joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components. Candidates for total knee replacement include elderly…
Read the full statement (159 words)
The Sigma Cruciate Retaining Porocoat Femoral Components are intended for cemented or cementless use as the femoral components of a Total Knee Replacement system.
Total Knee Replacement is intended to provide increased patient mobility and reduced pain by replacing the damaged knee joint articulation in patients where there is evidence of sufficient sound bone to seat and support the components.
Candidates for total knee replacement include elderly patients with a severely painful and/or severely disabled joint resulting from osteoarthritis, post-traumatic arthritis, rheumatoid arthritis, or a failed previous implant. Total knee replacement may be considered for younger patients if, in the opinion of the surgeon, an unequivocal indication for total knee replacement outweighs the risks associated with the age of the patient, and if limited demands regarding activity and kneejoint loading can be assured. This includes severely crippled patients with multiple joint involvement for whom a gain in knee mobility may lead to significant improvement in their quality of life.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K062654 · printed Nov 6, 2026
Cite this page
510(k) Report. “K062654: Depuy Sigma Cruciate Retaining Porocoat Femoral Components.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K062654
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026